GDF15 and metabolic dysfunction-associated steatotic liver disease: Further investigations are warranted to establish the causal or consequential role of GDF-15 in liver fibrosis and to further explore the potential implementation of circulating GDF-15 as a biomarker for liver fibrosis in patients with NAFLD and T2DM.